EP1575475A4
Regulation of type ii collagen gene expression using specific and selective electrical and electromagnetic signals
9 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO0162336A1 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1-6 |
| WO0162336A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
182 members in 20 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 267708 | United States of America | – | |
| 26770802 | United States of America | A | |
| 26770802 | United States of America | A | |
| 0331793 | United States of America | W | |
| 0331793 | United States of America | W | |
| 267708 | – | – | – |
| US20020267708 | – | – | – |
| US2003031793 | – | – | – |
| WO2003US31793 | – | – | – |
Members182
| Document | Office | Kind | |
|---|---|---|---|
| WO0162336A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4173701A | Australia | A | |
| EP1261391A1 | European Patent Office (EPO) | A1 | |
| US2003125769A1 | United States of America | A1 | |
| JP2003523271A | Japan | A | |
| US2003211084A1 | United States of America | A1 | |
| US2004006373A1 | United States of America | A1 | |
| CA2500212A1 | Canada | A1 | |
| WO2004029210A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2004073260A1 | United States of America | A1 | |
| AU2003276961A1 | Australia | A1 | |
| CA2501554A1 | Canada | A1 | |
| WO2004033644A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003279184A1 | Australia | A1 | |
| US2004138709A1 | United States of America | A1 | |
| WO2004033644A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2004247113A1 | Australia | A1 | |
| CA2528865A1 | Canada | A1 | |
| WO2004110552A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2004249202A1 | Australia | A1 | |
| CA2529374A1 | Canada | A1 | |
| WO2004112708A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2004253470A1 | Australia | A1 | |
| CA2530492A1 | Canada | A1 | |
| US2005010264A1 | United States of America | A1 | |
| WO2005002667A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP1261391A4 | European Patent Office (EPO) | A4 | |
| WO2004029210A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004112708A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20051947L | Norway | L | |
| NO20052254D0 | Norway | D0 | |
| KR20050056233A | Republic of Korea | A | |
| KR20050059198A | Republic of Korea | A | |
| NO20052254L | Norway | L | |
| US6919205B2 | United States of America | B2 | |
| AU2005206794A1 | Australia | A1 | |
| CA2553199A1 | Canada | A1 | |
| WO2005070136A2 | World Intellectual Property Organization (WIPO) | A2 | |
| BR0314807A | Brazil | A | |
| EP1560553A2 | European Patent Office (EPO) | A2 | |
| BR0315241A | Brazil | A | |
| MXPA05003259A | Mexico | A | |
| US2005203591A1 | United States of America | A1 | |
| MXPA05003785A | Mexico | A | |
| EP1575475A2 | European Patent Office (EPO) | A2 | |
| CR7789A | Costa Rica | A | |
| WO2005070136A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CN1694674A | China | A | |
| CN1703184A | China | A | |
| JP2006500989A | Japan | A | |
| JP2006501853A | Japan | A | |
| NO20060134L | Norway | L | |
| NO20060193L | Norway | L | |
| KR20060021366A | Republic of Korea | A | |
| KR20060024797A | Republic of Korea | A | |
| KR20060025568A | Republic of Korea | A | |
| NO20060414L | Norway | L | |
| US7022506B2 | United States of America | B2 | |
| EP1641518A1 | European Patent Office (EPO) | A1 | |
| IL172472D0 | Israel | D0 | |
| IL172508D0 | Israel | D0 | |
| IL172775D0 | Israel | D0 | |
| EP1643953A2 | European Patent Office (EPO) | A2 | |
| EP1644074A1 | European Patent Office (EPO) | A1 | |
| MXPA05013491A | Mexico | A | |
| CR8126A | Costa Rica | A | |
| CR8145A | Costa Rica | A | |
| BRPI0411369A | Brazil | A | |
| BRPI0411818A | Brazil | A | |
| CN1822807A | China | A | |
| US2006190043A1 | United States of America | A1 | |
| CN1826152A | China | A | |
| CR8165A | Costa Rica | A | |
| NO20063444L | Norway | L | |
| US2006235473A1 | United States of America | A1 | |
| ZA200503041B | South Africa | B | |
| IL176783D0 | Israel | D0 | |
| US7130692B2 | United States of America | B2 | |
| EP1716228A2 | European Patent Office (EPO) | A2 | |
| KR20060129256A | Republic of Korea | A | |
| ZA200503422B | South Africa | B | |
| JP2007500580A | Japan | A | |
| JP2007502693A | Japan | A | |
| CN1918285A | China | A | |
| ZA200600111B | South Africa | B | |
| MXPA05013493A | Mexico | A | |
| BRPI0506826A | Brazil | A | |
| ZA200600694B | South Africa | B | |
| JP2007517624A | Japan | A | |
| JP2007523671A | Japan | A | |
| NZ539310A | New Zealand | A | |
| EP1560553A4 | European Patent Office (EPO) | A4 | |
| EP1575475A4This record | European Patent Office (EPO) | A4 | |
| CN101076368A | China | A | |
| AU2007255038A1 | Australia | A1 | |
| CA2653431A1 | Canada | A1 | |
| WO2007142901A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2007299472A1 | United States of America | A1 | |
| EG23918A | Egypt | A | |
| NZ544525A | New Zealand | A |
Showing 100 of 182
65 legal events, as 9 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Definitive protectionFG2A | FG2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent invalid in the netherlands as no translation has been filedMP | MP | NL | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1575475
- Publication, DOCDB
- 1575475
- Publication, EPODOC
- EP1575475
- Application
- 3770683
- Application, DOCDB
- 03770683
- Application, EPODOC
- EP20030770683
Titles3
- German
- REGULIERUNG DER EXPRESSION VON TYP II KOLLAGEN-GENEN UNTER VERWENDUNG SPEZIFISCHER UND SELEKTIVER ELEKTRISCHER SOWIE ELEKTROMAGNETISCHER SIGNALE
- English
- REGULATION OF TYPE II COLLAGEN GENE EXPRESSION USING SPECIFIC AND SELECTIVE ELECTRICAL AND ELECTROMAGNETIC SIGNALS
- French
- REGULATION DE L'EXPRESSION GENIQUE DU COLLAGENE DE TYPE II AU MOYEN DE SIGNAUX ELECTRIQUES ET ELECTROMAGNETIQUES SPECIFIQUES ET SELECTIFS
Classification
- CPC, 6
- A61N1/326
- C12N15/67
- A61N1/40
- C12N13/00
- C12N15/63
- C12N15/85
- IPC, 8
- A61N1 32
- A61N1 40
- A61N2 04
- C12N5 07
- C12N5 077
- C12N13 00
- A61H1 00
- A61F7 00
Designated states1
- Contracting states, 1
- Türkiye
